InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), One World Products Inc. (OWPC) Team up to Deliver Sports Performance/Recovery Drinks

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, and One World Products (OTCQB: OWPC), the largest Black-controlled, fully-licensed hemp and cannabis producer in Colombia, today announced entry into an active collaboration agreement. Under the agreement, the two companies will combine their strong, symbiotic capabilities to develop an innovative line of next-generation sports performance/recovery drinks. “Partnering with Isiah and his exceptional team at OWPC is an extraordinary opportunity for PBIO to accelerate the visibility and impact of our revolutionary UltraShear nanoemulsions platform technology. Isiah is a world-renowned figure in the world of sports and more broadly as a role model in Black-owned business leadership, and it is a privilege for our companies to team up! OWPC has become a leading producer of the highest quality and sustainably sourced hemp-derived CBD in Colombia and is closely partnered with their government and indigenous populations,” said Richard T. Schumacher, president and CEO of PBIO. “Teamed with PBIO’s best-in-class nanoemulsions processing, OWPC is uniquely positioned to deliver these solutions and drive rapid recognition and acceptance across the worlds of professional and amateur sports. This is going to be exciting and, we believe, very successful!”

To view the full press release, visit https://ibn.fm/wB2Vo

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) patented technology from BaroFold Inc. (the BaroFold technology) that allows entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.